# Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

> **NCT04957511** · — · RECRUITING · sponsor: **Viome** · enrollment: 30 (estimated)

## Conditions studied

- Gynecologic Cancer
- Immunotherapy
- Gut Microbiome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04957511
- **Lead sponsor:** Viome
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-29
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04957511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04957511, "Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04957511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*